Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up

NAUnknownINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
CD
Interventions
DIAGNOSTIC_TEST

Colonoscopy

Colonoscopy for CD patients in clinical remission

Trial Locations (14)

3000

Leuven University Hospital, Leuven

92110

APHP- Hopital BEAUJON, Clichy

Unknown

AZ Sint Lucas Gent, Ghent

UZ Leuven, Leuven

CHU Liège, Liège

CHU Besançon - Hôpital Jean Minjoz, Besançon

CHU Estaing - Clermont Ferrand, Clermont-Ferrand

CHRU de Lille - Hôpital C. Huriez, Lille

CHU Montpellier - Hôpital Saint Eloi, Montpellier

CHU Nancy - Hôpital Barbois, Nancy

CHU Nantes - Hôtel Dieu, Nantes

CHU de Nice - Hôpital de l'Archet 2, Nice

Hôpital Saint Antoine, Paris

CHU Bordeaux - Hôpital Haut Lévêque, Pessac

All Listed Sponsors
collaborator

AbbVie

INDUSTRY

collaborator

Biogen

INDUSTRY

collaborator

Celgene

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Takeda

INDUSTRY

lead

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER